Keith Jones

9PUBLICATIONS
50CO-AUTHORS
Molecular targetsProteins and peptidesBiologically active moleculesBiomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Apr 05, 2023
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.

A Elisa Pasqua, Swee Y Sharp, Nicola E A Chessum

|Nov 15, 2019
Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72.

Jonathan Pettinger, Michael Carter, Keith Jones

|Dec 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).

Nicola E A Chessum, Swee Y Sharp, John J Caldwell

|Sep 07, 2017
Synthetic Study toward Total Synthesis of (±)-Germine: Synthesis of (±)-4-Methylenegermine.

Gilbert Stork, Ayako Yamashita, Robert M Hanson

|Aug 31, 2017
Lysine-Targeting Covalent Inhibitors.

Jonathan Pettinger, Keith Jones, Matthew D Cheeseman

Pageof 2

Frequent Collaborators

7 joint publications

Matthew D Cheeseman

3 joint publications

Nicola E A Chessum

3 joint publications

Elisa Pasqua

3 joint publications

Paul Workman